News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
628,572 Results
Type
Article (55111)
Company Profile (85)
Press Release (573376)
Section
Business (173198)
Career Advice (2689)
Deals (32457)
Drug Delivery (93)
Drug Development (75883)
Employer Resources (153)
FDA (14802)
Job Trends (13847)
News (303614)
Policy (29033)
Tag
Academia (2668)
Alliances (43146)
Alzheimer's disease (1176)
Approvals (14745)
Artificial intelligence (147)
Bankruptcy (284)
Best Places to Work (10803)
Breast cancer (180)
Cancer (1284)
Cardiovascular disease (97)
Career advice (2272)
CAR-T (91)
Cell therapy (277)
Clinical research (60611)
Collaboration (432)
Compensation (147)
COVID-19 (2467)
C-suite (118)
Data (1322)
Diabetes (143)
Diagnostics (5964)
Earnings (59029)
Employer resources (134)
Events (92903)
Executive appointments (376)
FDA (15427)
Funding (394)
Gene therapy (182)
GLP-1 (542)
Government (4416)
Healthcare (18072)
Infectious disease (2548)
Inflammatory bowel disease (109)
Interviews (517)
IPO (14706)
Job creations (3401)
Job search strategy (1915)
Layoffs (448)
Legal (6394)
Lung cancer (179)
Manufacturing (179)
Medical device (12381)
Medtech (12385)
Mergers & acquisitions (17922)
Metabolic disorders (383)
Neuroscience (1468)
NextGen Class of 2024 (6333)
Non-profit (4330)
Northern California (1468)
Obesity (216)
Opinion (215)
Patents (111)
People (57709)
Phase I (19107)
Phase II (26814)
Phase III (19531)
Pipeline (474)
Postmarket research (2354)
Preclinical (8020)
Radiopharmaceuticals (241)
Rare diseases (241)
Real estate (5942)
Regulatory (19571)
Research institute (2459)
Resumes & cover letters (404)
Southern California (1302)
Startups (3315)
United States (13342)
Vaccines (544)
Weight loss (147)
Date
Today (35)
Last 7 days (664)
Last 30 days (2514)
Last 365 days (32303)
2024 (31528)
2023 (36422)
2022 (46728)
2021 (51653)
2020 (50673)
2019 (44643)
2018 (34002)
2017 (30525)
2016 (29826)
2015 (35156)
2014 (28164)
2013 (24498)
2012 (25746)
2011 (25973)
2010 (24384)
Location
Africa (857)
Arizona (134)
Asia (36937)
Australia (6645)
California (3281)
Canada (1271)
China (265)
Colorado (158)
Connecticut (160)
Europe (85406)
Florida (476)
Georgia (124)
Illinois (380)
Indiana (194)
Kansas (89)
Maryland (573)
Massachusetts (2456)
Michigan (170)
Minnesota (242)
New Jersey (993)
New York (950)
North Carolina (721)
Northern California (1468)
Ohio (134)
Pennsylvania (798)
South America (1165)
Southern California (1302)
Texas (493)
Utah (100)
Washington State (353)
628,572 Results for "institute of psychiatry".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adams Clinical Announces Expansion into Inpatient Psychiatry and Schizophrenia Clinical Trial Capabilities with Signing of Partnership with InSite Clinical Research
December 11, 2024
·
4 min read
Relmada Therapeutics Announced Publication of Results from the Phase 3 Reliance I Study of REL-1017 in The Journal of Clinical Psychiatry
Relmada Therapeutics, Inc. today announced the publication of REL-1017 clinical data from the Reliance I Study in the peer-reviewed journal, The Journal of Clinical Psychiatry.
June 18, 2024
·
5 min read
Alkermes Highlights Data Presentations Related to its Psychiatry Franchise at Spring 2024 Scientific Conferences
Alkermes plc announced the presentation of research related to its psychiatry franchise products—LYBALVI® and ARISTADA® —at four scientific conferences this spring.
May 14, 2024
·
20 min read
Immutep successfully completes institutional placement and institutional component of entitlement offer
Immutep Limited ACN 009 237 889 is pleased to announce the successful completion of its institutional placement and the institutional component of its 1 for 16 pro rata accelerated non-renounceable entitlement offer of new fully paid ordinary shares in Immutep.
June 5, 2024
·
7 min read
Biotech Bay
UCSF QBI and the Department of Psychiatry and Behavioral Sciences Announce Breakthrough Research Findings in the Molecular Understanding of Autism
The Quantitative Biosciences Institute, in collaboration with the Department of Psychiatry and Behavioral Sciences, at the University of California, San Francisco, reported new breakthrough research findings in the understanding of autism spectrum disorder.
December 4, 2023
·
5 min read
Genetown
Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting
Seaport Therapeutics, a clinical-stage biopharmaceutical company that is charting a proven path in neuropsychiatry, announced two poster presentations detailing the results from multiple clinical trials of SPT-300 at the Society of Biological Psychiatry Annual Meeting in Austin, TX.
May 9, 2024
·
7 min read
Press Releases
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire its First Florida Interventional Psychiatry Clinics
October 30, 2024
·
4 min read
Genetown
PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting
PureTech Health plc today announced two poster presentations detailing the results from multiple clinical trials of SPT-300 at the Society of Biological Psychiatry Annual Meeting in Austin, TX.
May 9, 2024
·
10 min read
Pipeline
J&J Scraps Pipeline Assets Including Alzheimer’s and Parkinson’s Candidates
Johnson & Johnson is cutting several programs—most of which are in neurology and psychiatry—as the company also pulls back from the infectious diseases market.
October 16, 2024
·
2 min read
·
Tristan Manalac
Circular Genomics Raises $8.3 Million for Debut of Circular RNA Assay in Precision Psychiatry
Circular Genomics, the global leader in advancing circular RNA biomarkers for precision psychiatry and neurology, today announced the closing of an $8.3 Million Series A investment round.
January 24, 2024
·
3 min read
1 of 62,858
Next
